Organization (Nonprofit)
Children's Cancer and Leukaemia Group
ClinicalTrials.gov lists Children's Cancer and Leukaemia Group as lead sponsor of 46 trials. It has 18 active development programs and 39 approved assets.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers Children's Cancer and Leukaemia Group: 46 lead-sponsored trials and 1 legal-entity registration.
Disease areas (44)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Neuroblastoma | 14 |
| Sarcoma | 8 |
| Glioma | 7 |
| Lymphoma | 6 |
| Kidney Neoplasms | 4 |
Showing 5 of 44 disease areas.
Trials by start year as sponsor or collaborator (17)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2023 | 1 |
| 2021 | 1 |
| 2009 | 1 |
| 2008 | 5 |
| 2007 | 3 |
| 2006 | 5 |
| 2005 | 6 |
| 2004 | 4 |
| 2003 | 3 |
| 2002 | 2 |
Showing 10 of 17 years.
Recruitment duration, a model prediction: none of the 46 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Active development programs (18)
Shown in this order: max phase, then active trials.
| Drug | Disease area | Max phase | Trials |
|---|---|---|---|
| CYCLOPHOSPHAMIDE | Radiation Injuries | Not reported | 1 |
| CYCLOPHOSPHAMIDE | Drug-Related Side Effects and Adverse Reactions | Not reported | 1 |
| Adjuvant Therapy | Ototoxicity | Not reported | 1 |
| Adjuvant Therapy | Radiation Injuries | Not reported | 1 |
| CYCLOPHOSPHAMIDE | Ototoxicity | Not reported | 1 |
Showing 5 of 18 active programs.
Approved assets (39)
Shown in this order: max phase first.
| Drug | Trials |
|---|---|
| Vincristine | 17 |
| ETOPOSIDE | 15 |
| CARBOPLATIN | 14 |
| CYCLOPHOSPHAMIDE | 14 |
| CISPLATIN | 14 |
Showing 5 of 39 approved assets.
Journals published in (38)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Pediatric blood & cancer | 8 |
| British journal of haematology | 7 |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 7 |
| Blood | 4 |
| Blood advances | 4 |
Showing 5 of 38 journals.
Organization relationships (12)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Societe Francaise Oncologie Pediatrique | Co sponsors trial with | 5 |
| German Society for Pediatric Oncology and Hematology GPOH gGmbH | Co sponsors trial with | 2 |
| Societe Internationale d'Oncologie Pediatrique | Co sponsors trial with | 2 |
| Swiss Cancer Institute | Co sponsors trial with | 1 |
| European Paediatric Soft Tissue Sarcoma Study Group | Co sponsors trial with | 1 |
Showing 5 of 12 relationships.
Latest dated events (51)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2023-02-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2021-09-14 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2009-02 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2008-08 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2008-07 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 51 events.
Biomarker capability evidence (14)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| AFP | Trial sponsor | Mentioned in trial text |
| AFP | Trial sponsor | Mentioned in trial text |
| AFP | Trial sponsor | Mentioned in trial text |
| BAMBI | Trial sponsor | Mentioned in trial text |
| CD34 | Trial sponsor | Mentioned in trial text |
Showing 5 of 14 evidence rows.
On Scientist.com
Children's Cancer and Leukaemia Group is listed as a research supplier in the Scientist.com network.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, sponsor delivery record, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarkers this organization publishes on.
Work with Children’s Cancer and Leukaemia Group (CCLG) Tissue Bank on Scientist.com
For prices, more details, or to contact Children’s Cancer and Leukaemia Group (CCLG) Tissue Bank, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.